Related Experiment Video
Updated: Aug 14, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in
1Division of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee 37232, USA.
Abstract:
Progressive tissue fibrosis can compromise epithelial function resulting in organ failure. Appreciating evidence suggests that fibroblasts provide fibrogenic collagens during such injury. We further tested this notion by attempting to reduce the physiologic consequences of organ fibrosis through the selective killing of fibroblasts at sites of injury. Here, we report the conditional reduction of tissue fibroblasts using the coding sequence for herpesvirus thymidine kinase (DeltaTK) put under the control of a cell-specific promoter from the gene encoding fibroblast-specific protein 1 (FSP1). Transgenic fibroblasts from mice carrying FSP1.DeltaTK minigenes expressed thymidine kinase concordantly with native FSP1 and, compared to transgenic epithelium, were selectively susceptible to the lethal effects of nucleoside analogs either in culture or during experimental renal fibrosis. The numbers of fibroblasts in fibrogenic kidney tissue were reduced on exposure to nucleoside analogs as was the degree of type I collagen deposition and the extent of fibrosis. Fibroblast reduction following the stress of DNA chain termination highlights the important contribution of cell division during fibrogenesis. Our findings convey a proof of principle regarding the importance of FSP1(+) fibroblasts in fibrosis as well as providing a new approach to treating the relentless scarification of tissue.
Insights
Targeting fibroblasts, the cells driving tissue fibrosis, offers a new therapeutic strategy. Selective elimination of fibroblast-specific protein 1 (FSP1) positive fibroblasts reduced organ scarring and improved function.
Area of Science:
- Cell Biology
- Organ Fibrosis
- Tissue Repair
Background:
- Progressive tissue fibrosis impairs organ function and can lead to failure.
- Fibroblasts are implicated in producing fibrogenic collagens during tissue injury.
Purpose of the Study:
- To investigate the selective elimination of fibroblasts at injury sites.
- To assess the therapeutic potential of targeting FSP1(+) fibroblasts in organ fibrosis.
Main Methods:
- Development of transgenic mice expressing herpesvirus thymidine kinase (DeltaTK) under the fibroblast-specific protein 1 (FSP1) promoter.
- Selective killing of FSP1(+) fibroblasts using nucleoside analogs in vitro and during experimental renal fibrosis.
- Quantification of fibroblast numbers, type I collagen deposition, and fibrosis extent.
Main Results:
- Transgenic fibroblasts selectively expressed thymidine kinase and were susceptible to nucleoside analogs.
- Exposure to nucleoside analogs reduced fibroblast numbers in fibrogenic kidney tissue.
- Type I collagen deposition and the extent of fibrosis were significantly reduced.
Conclusions:
- Fibroblast reduction via DNA chain termination highlights the role of cell division in fibrogenesis.
- FSP1(+) fibroblasts are crucial in fibrosis development.
- This study provides a proof of principle for targeting FSP1(+) fibroblasts as a novel therapeutic approach for tissue fibrosis.

